RxDoctor Payments Data

Barbara Burns, MD

Obstetrics & Gynecology · Madison, WINPI 1225082522

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,118 of the $9,758 with a category attached, or 62.7%. Intuitive Surgical accounts for 95.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $7,013 and has fallen 99.6% since, to $25 in 2025. Among obstetrics & gynecology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,758in general payments, 2019–2025

Across 37 payments — averaging $263.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$9K
  • AbbVie$126
  • AMAG Pharmaceuticals, Inc.$101
  • Astellas Pharma US Inc$61
  • Roche Diagnostics Corporation$53
  • Pfizer$47
  • plus $53 from 2 others

What the payments were for

  • Travel & lodging$3,17633%
  • Food & beverage$4635%
  • Education$6,11863%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,758 in reported general payments places this provider in the 95th percentile of 568 obstetrics & gynecology providers in Wisconsin.

See all obstetrics & gynecology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$3,252
Medicare patients
15
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$2,368
Medroxyprogesterone Acetate11$74

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$47$2,36812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 568 obstetrics & gynecology providers in Wisconsin.

Other obstetrics & gynecology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →